Maryland HB 25: Public Health - Prescription Drug Monitoring Program - Revisions

Status: Approved by the Governor - Chapter 531 (as of 2019-05-13)

State: Maryland · Session: 2019 · Bill: HB 25

Subjects: Public Health, Administrative Agencies, Committees and Commissions, Controlled Dangerous Substances, Crimes and Punishments, Data, Drugs, Education, Ethics, Examinations, Health, Health Occupations, Investigations and Inquiries, Job Training, Licenses, Notices, Penalties and Sentences, Pharmacists and Pharmacies, Reports, Safety, Substance Abuse, Telecommunications and Information Technology

Sponsors: Barron, Bagnall, Bhandari, Carr, Charles, Chisholm, Cullison, Hettleman, Hill, Johnson, K. Young, Kelly, Kerr, Kipke, Korman, Krebs, Metzgar, Moon, Morgan, Pena-Melnyk, Pendergrass, R. Lewis, Rosenberg, Saab, Sample-Hughes

View Maryland HB 25 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.